Our mission is to expand the scope and impact of genomics in medicine.
Through innovative products, dedicated patient care, and collaborative research, Recombine is empowering families and revolutionizing personalized medicine.
Recombine is driven by dedicated leaders from a diverse number of fields.
Our work culture is founded on Recombine's core values of innovation, collaboration, responsibility, openness, and service.
Phone: 855-OUR-GENES (855-687-4363)
Location: 1140 Broadway, Suite 1100, New York 10001
Dr. Grifo's career in reproductive medicine began in 1988. He has focused his research on Preimplantation Genetic Diagnosis, resulting in the first U.S. baby born following this procedure. Dr. Grifo received his doctorate in biochemistry, and his medical degree, from Case Western Reserve University. He completed residency at the New York Hospital-Cornell Medical Center and fellowship in reproductive endocrinology at Yale University. Board certified in obstetrics and gynecology, and reproductive endocrinology, Dr. Grifo also is accredited in advanced operative laparoscopy and hysteroscopy through the American Association of Gynecologic Laparoscopists. An elected member of Phi Beta Kappa and Alpha Omega Alpha (AOA), Dr. Grifo has received many honors during his career, including several fellowship awards.
In 1996, he received the President's Award from RESOLVE. In 1997, Dr. Grifo was named one of the '401 Best Doctors for Women in America' by Good Housekeeping magazine, and has been designated one of the best doctors in New York by New York Magazine yearly since 1996. He has presented several prize papers at the American Society of Reproductive Medicine Dr. Grifo has published more than 135 medical and scientific articles in addition to numerous book chapters, and he speaks frequently at medical-scientific meetings and symposia. He has directed the research efforts at NYU, which has resulted in many improvements in assisted reproduction including nuclear transfer, blastocyst transfer, oocyte freezing and Preimplantation Genetic Diagnosis. He is an active member, and has held office in the American Society for Reproductive Medicine (ASRM) and is a past president of The Society for Assisted Reproduction (SART).
Dr. Serena Chen serves as a Medical Advisor in Reproductive Endocrinology and Infertility for Recombine. Dr. Chen graduated from Brown University, and attended the Duke University School of Medicine, and trained in gynecology and obstetrics at Johns Hopkins Hospital. She had a hard time deciding what to do there because she loved delivering babies, loved doing surgery, and loved seeing patients in the office. Of all the wonderful things in the field of obstetrics and gynecology, she finally decided she was most fascinated by the world of test tube babies or IVF (in vitro fertilization) and so did her subspecialty training and became board-certified in reproductive endocrinology and infertility, which she practices to this day.
She is honored that she has been voted by her peers to be a top doctor in the New Jersey Monthly survey every year from 2007 to 2014, and has also received Best Doctor honors from Castle Connolly, New York Magazine, and others. She is currently Director of Reproductive Medicine at IRMS (Institute for Reproductive Medicine and Science) at Saint Barnabas and Clinical Associate Professor at Rutgers, UMDNJ New Jersey Medical School. Dr. Chen loves inspiring her patients with information and ideas about their mental and physical health in an interesting and accessible way. In the office she does this one person at a time.
She hopes to use technology and social media platforms to give many more people who cannot come into the office relevant, practical, accessible, and interesting information that they can use to live better, healthier lives. Please follow her on Twitter and Instagram @DrSerenaHChen or visit her at www.sbivf.com.
Co-founder and Medical Director of the Southern California Reproductive Center, Dr. Mark Surrey is a leader in the field of fertility and reproductive medicine, including reproductive surgery and in vitro fertilization (IVF). Dr. Surrey, a reproductive endocrinologist, is board-certified in obstetrics and gynecology. He serves as Associate Clinical Professor in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA. He is also Associate Director for Advanced Technologies at the Center for Fertility and Reproductive Medicine at Cedars-Sinai Medical Center.
Dr. Surrey is past president of the American Association of Gynecologic Laparoscopists (AAGL), the largest association of minimally invasive gynecologists in the United States, and the leading organization of its kind worldwide. He is also past president of the Pacific Coast Reproductive Society, the premier society of IVF specialists in the western United States. Dr. Surrey is a prolific researcher, authoring numerous publications for leading peer-reviewed journals including Fertility and Sterility and the Journal of Assisted Reproduction and Genetics. Voted one of the 'Top 100 Health Professionals' and listed in 'Best Doctors in America,' Dr. Surrey's ability to help people achieve their fertility goals has made him a physician of choice for patients from all over the world for more than 25 years. Dr. Surrey earned his bachelor's degree from the University of Pittsburgh and his M.D. from George Washington University. Following an internship and residency at UCLA Medical Center, he completed a research Fellowship in Reproductive Endocrinology and an Infertility Fellowship at the University of London, Hammersmith Hospital. He trained in Preimplantation Genetic Diagnosis at the University of London and Monash University, Melbourne.
David I. Hoffman, M.D., is subspecialty certified in Reproductive Endocrinology and Infertility, has over 23 years of experience in the diagnosis and treatment of infertility, and has published over 65 abstracts, articles, and book chapters. He joined Doctor Maxson at the Northwest Center for Infertility and Reproductive Endocrinology in 1989.
Prior to coming to South Florida he served on the faculty at the University of Southern California in Los Angeles, as Professor in the Department of Obstetrics and Gynecology at Northwestern University in Chicago, Director of the IVF Program at Northwestern Memorial Hospital, and Section Head of the Division of Reproductive Endocrinology and Infertility at Northwestern University Medical School. Currently, in addition to working at our Fort Lauderdale-area offices as an infertility specialist, David I. Hoffman, M.D., also serves as a Voluntary Associate Professor in the Department of Obstetrics and Gynecology at the University of Miami, School of Medicine.
Kelly Ketterson serves as a Scientific Advisor in Embryology and Infertility for Recombine. She has had considerable experience growing and managing an emerging genetics company. Ms. Ketterson served as the Director of Operations at Reprogenetics. In her role at Recombine she is responsible for Client Services, Marketing, Sales, Public Relations, Community Relations and Execution. Ms. Ketterson completed a Masters Program in Biomedical Science at the Jones Institute at Eastern Virginia Medical School and is a highly experienced clinical embryologist.
She worked under the direction of Dr. Jacques Cohen from 1996-2004 at The Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center performing routine IVF procedures, clinical research trials, and conferences specializing in the continuing education of reproductive endocrinologists, IVF nurses, embryologists, andrologists and administrative staff. Prior to her career in reproductive woman's health, Ms. Ketterson worked for six years as a health care consultant for Buck Consultants, Inc.
Dr. Wells has been involved in Preimplantation Genetic Diagnosis (PGD) and the study of human gametes and embryos since 1992. Shortly after obtaining his PhD he was awarded a Medical Research Council Fellowship, during the course of which he successfully developed the first strategy for screening the entire set of chromosomes in single cells using comparative genomic hybridisation (CGH). He stayed on at the college as a Medical Research Council Research Fellow in the Department of Obstetrics & Gynecology until 1999.
He worked in the UCL Centre for Preimplantation Genetic Diagnosis from 1999 to 2002 before coming to the United States. In 2000 he joined Reprogenetics where he initiated the there their single gene PGD program, which has grown exponentially since its inception. In 2003, he took a position at Yale University, where he spent four years as an Assistant Professor in the Department of Obstetrics and Gynecology. Dagan and his research team relocated to the Nuffield Department of Obstetrics and Gynaecology at the University of Oxford at the end of 2007, where he is currently an associate professor. The following year he assisted in setting up Reprogenetics-UK where he is a founder and Director. During this period Dagan and his group, in collaboration with Reprogenetics, began clinical trials of CGH applied to human oocytes and blastocysts, which have led to some of the highest IVF pregnancy rates recorded to date. Dagans work has been recognized with several prizes, including the American Society for Reproductive Medicine General Program Prize (2000) and the publication of more than 80 papers in peer-review journals. Dagan is a Fellow of the Royal Society of Pathologists and serves on the editorial boards of several international medical journals.
Dr. Nagy obtained his MD (1986) and his Ob/Gyn degrees (1996) at the Semmelweis Medical University in Budapest. His PhD was granted at the Free University of Brussels in 1997, where he worked in the team that developed the ICSI procedure. More recently, he has contributed to the development of a highly efficient oocyte cryopreservation procedure that gave bases to establishing the first donor cryobank in USA. He is author of more than 150 publications and book chapters. Dr. Nagy serves on the board of several different societies; as well he is Associate Editor for Human Reproduction and RBMonline. Currently, Dr. Nagy is the Scientific and Laboratory Director at Reproductive Biology Associates, Atlanta, USA.
Ms. Fischer is a Scientific Advisor in Genetic Counseling for Recombine. Ms. Fischer was the Preimplantation Genetic Diagnosis Program Coordinator and Genetic Counselor for Reprogenetics beginning in 2004. Before Reprogenetics, Ms. Fischer held the same titles at The Institute for Reproductive Medicine and Science (IRMS) at Saint Barnabas Medical Center. Prior to joining IRMS, Ms. Fischer worked at Spectrum Health Genetic Services where she prepared and organized in-house and outreach pediatric genetics clinics, and counseled patients regarding diagnosis, recurrence risks, testing options, test results and follow-up care.
From 1993 to 1995, she was a Lecturer and Genetic Counselor at the Eastern Virginia Medical School in Norfolk, Virginia. She received her undergraduate degree in Pre-medicine from Northwestern University in 1991 and a Master of Science degree in Genetic Counseling in 1993 from University of South Carolina.
Dr. Howard Levy is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cancer genetics, clinical genetics and Ehlers Danlos syndrome. Dr. Levy serves as the clinical director of Johns Hopkins Internal Medicine at Green Spring Station.
Dr. Levy received his undergraduate degree from the University of Maryland. He earned his Ph.D. and M.D. from the University of Maryland at Baltimore. He completed his residency at Boston Medical Center and performed a fellowship in genetics at the National Institutes of Health.
His research interests include genetics education and heritable disorders of connective tissue.
Emily Mounts, MS, is a board-certified genetic counselor at Oregon Reproductive Medicine, a globally recognized fertility clinic. She is the Director of ORM Genomics, a program dedicated to the integration of clinical and laboratory genetics into the care of patients with infertility. Emily completed her Bachelor’s degree at the University of Michigan and her Master’s degree in Genetic Counseling at the Medical College of Virginia. She has been a clinical genetic counselor for 18 years, during which time she has counseled thousands of patients to help them make informed choices about prenatal and preconception testing.
Her professional interests include the genetic causes of infertility, carrier screening, egg and sperm donor screening, prenatal diagnosis, and ethical issues in preimplantation genetic testing.